Positionspapier zur Bedeutung psychosozialer Faktoren in der Kardiologie

Orth-Gomér K, Wamala SP, Horsten M (2000) Marital stress worsens prognosis in women with coronary heart disease: the Stockholm Female Coronary Risk Study. JAMA 284:3008–3014

Low CA, Thurston RC, Matthews KA (2010) Psychosocial factors in the development of heart disease in women: current research and future directions. Psychosom Med 72:842–854

Ladwig KH, Marten-Mittag B, Formanek B (2000) Gender differences of symptom reporting and medical health care utilization in the German population. Eur J Epidemiol 16:511–518

Büchner B, Kleiber C, Stanske B (2005) Stress und Herzkrankheit bei Frauen: Geschlechtspezifische Risiken, Bewältigungsprobleme und Behandlungsansätze. Herz 30:416–428

Wittstein IS, Thiemann DR, Lima JA (2005) Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 352:539–548

Orth-Gomér K, Schneiderman N, Wang HX (2009) Stress reduction prolongs life in women with coronary disease: the Stockholm Women’s Intervention Trial for Coronary Heart Disease (SWITCHD). Circ Cardiovasc Qual Outcomes 2:25–32

Gulliksson M, Burell G, Vessby B (2011) Randomized controlled trial of cognitive behavioral therapy vs. standard treatment to prevent recurrent cardiovascular events in patients with coronary heart disease: secondary prevention in Uppsala Primary Health Care Project (SUPRIM). Arch Intern Med 171:134–140

Linden W, Phillips MJ, Leclerc J (2007) Psychological treatment of cardiac patients: a meta-analysis. Eur Heart J 28:2972–2984

Barth J, Schneider S, Känel R van (2010) Lack of social support in the etiology and the prognosis of coronary heart disease: a systematic review and meta-analysis. Psychosom Med 72:229–238

Parkes M, Benjamin B, Fitzgerald RG (1969) Broken heart: a statistical study of increased mortality among widowers. Brit Med J 1:740–743

Mostofsky E, Maclure M, Sherwood JB (2012) Risk of acute myocardial infarction after the death of a significant person in one’s life. The Determinants of Myocardial Infarction Onset Study. Circulation 125:491–496

Hemminki K, Jiang Y (2002) Cancer risks among long-standing spouse. Br J Cancer 86:1737–1740

Pedersen S, Sears S, Burg M (2009) Does ICD indication affect quality of life and levels of distress? Pacing Clin Electrophysiol:153–156

Titscher G, Schöppl C (2000) Die Bedeutung der Paarbeziehung für Genese und Verlauf der koronaren Herzkrankheit. Verlag für Akademische Schriften, Frankfurt/M.

Ji J, Zöller B, Sundquist K (2012) Increased risks of coronary heart disease and stroke among spousal caregivers of cancer patients. Circulation 125:1742–1747

Bromberg JI, Beasley PJ, D‘Angelo EJ (2003) Depression and anxiety in adults with congenital heart disease: a pilot study. Heart Lung 32:105–110

Massaro AN, El-Dib M, Glass P (2008) Factors associated with adverse neurodevelopmental outcomes in infants with congenital heart disease. Brain Dev 30:437–446

Warnes CA, Williams RG, Bashore TM (2008) ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Circulation 118:e714–e833

Barker DJ, Gluckman PD, Godfrey KM (1993) Fetal nutrition and cardiovascular disease in adult life. Lancet 341:938–941

Dong M, Giles WH, Felitti VJ (2004) Insights into causal pathways for ischemic heart disease: adverse childhood experiences study. Circulation 110:1761–1766

Clarc AP, McDougall G (2006) Cognitive impairment in heart failure. Dimens Crit Care Nurs 25:93–100

Dickson VV, Tkacs N, Riegel B (2007) Cognitive influences on self-care decision making in persons with heart failure. Am Heart J 154:424–431

Vogels RL, Scheltens R, Schoreder-Tanka JM (2007) Cognitive impairment in heart failure: a systematic review of literature. Eur J Heart Fail 9:440–449

Kindermann I, Fischer D, Karbach J (2012) Cognitive function in patients with decompensated heart failure: the Cognitive Impairment in Heart Failure (Coglmpair-HF) study. Eur J Heart Fail 14:404–413

Qiu C, Winblad B, Marengoni A (2006) Heart failure and risk of dementia and Alzheimer disease. Arch Int Med 166:1003–1008

Sachs GA, Carter R, Holtz LR (2011) Cognitive impairment: an independent predictor of excess mortality. Ann Intern Med 155:300–308

Finset A (2011) Research on person-centered clinical care. J Eval Clin Pract 17:384–386

Lewin SA, Skea ZC, Entwistle V (2001) Interventions for providers to promote a patient centered approach in clinical consultations. Cochrane Database Syst Rev CD003267

Langewitz W, Adler RH, Herzog W (2011) Uexküll Psychosomatische Medizin. Theoretische Modelle und klinische Praxis, 7. Aufl. Urban & Fischer, München

Prochaska J, DiClemente C (1983) Stages and process of self change of smoking: towards an integrative modell of change. J Consult Clin Psychol 54:390–395

Cahill K, Lancaster T, Green N (2010) Stage-based interventions for smoking cessation. Cochrane Database Syst Rev CD004492

Thompson DR, Yu CM (2003) Quality of life in patients with coronary heart disease-I: assessment tools. Health Qual Life Outcomes 1:42

Eurich DT, Johnson JA, Reid KJ (2006) Assessing responsiveness of generic and specific health related quality of life measures in heart failure. Health Qual Life Outcomes 4:89

Garin O, Ferrer M, Pont A (2009) Disease-specific health-related quality of life questionnaires for heart failure: a systematic review with meta-analyses. Qual Life Res 18:71–85

Dyer MT, Goldsmith KA, Sharples LS (2010) A review of health utilities using the EQ-5D in studies of cardiovascular disease. Health Qual Life Outcomes 8:13

Faller H, Störk S, Schowalter M (2007) Is health-related quality of life an independent predictor of survival in patients with chronic heart failure? J Psychosom Res 63:533–538

Sparrenberger F, Cichelero FT, Ascoli AM (2009) Does psychosocial stress cause hypertension? A systematic review of observational studies. J Hum Hypertens 23:12–19

Jonas BS, Franks P, Ingram DD (1997) Are symptoms of anxiety and depression risk factors for hypertension? Longitudinal evidence from the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch Fam Med 6:43–49

Abouzeid M, Kelsall HL, Forbes AB (2012) Posttraumatic stress disorder and hypertension in Australian veterans of the 1991 Gulf War. J Psychosom Res 72:33–38

Kinzie JD, Riley C, McFarland B (2008) High prevalence rates of diabetes and hypertension among refugee psychiatric patients. J Nerv Ment Dis 196:108–112

Kaplan MS, Nunes A (2003) The psychosocial determinants of hypertension. Nutr Metab Cardiovasc Dis 13:52–59

Wang Q, Xi B, Liu M (2012) Short sleep duration is associated with hypertension risk among adults: a systematic review and meta-analysis. Hypertens Res 35(10):1012–1018

Linden W, Moseley J (2006) The efficacy of behavioral treatments for hypertension. Appl Psychophysiol Biofeedback 31:51–63

Dickinson H, Campbell F, Beyer F (2008) Relaxation therapies for the management of primary hypertension in adults. Cochrane Database Syst Rev 23:CD004935

Shin JY, Suls J, Martin R (2008) Are cholesterol and depression inversely related? A meta-analysis of the association between two cardiac risk factors. Ann Behav Med 36:33–43

Golomb BA (1998) Cholesterol and violence: is there a connection? Ann Intern Med 128:478–487

Garland M, Hallahan B, McNamara M (2007) Lipids and essential fatty acids in patients presenting with self-harm. Br J Psychiatry 190:112–127

Tedders SH, Fokong KD, McKenzie LE (2011) Low cholesterol is associated with depression among US household population. J Affect Disord 135:115–121

Reedt Dortland AK van, Giltay EJ, Veen T van (2010) Associations between serum lipids and major depressive disorder: results from the Netherlands Study of Depression and Anxiety (NESDA). J Clin Psychiatry 71:729–736

Letho SM, Ruusunen A, Niskanen L (2010) Elevated depressive symptoms and compositional changes in LDL particles in middle-aged men. Eur J Epidemiol 25:403–409

Hummel J, Westphal S, Weber-Hamann B (2011) Serum lipoproteins improve after sucessful pharmacologic antidepressant treatment: a randomized open-label prospective trial. J Clin Psychiatry 72:885–891

Köllner V (2011) Tabakentwöhnung – eine Aufgabe für die ärztliche Psychotherapie? Ärztl Psychother 6:217–222

Fiore MC, Baker TB (2011) Treating smokers in the health care setting. N Engl J Med 365:1222–1231

Lai DT, Cahill K, Quin Y (2010) Motivational interviewing for smoking cessation. Cochrane Database Syst Rev 1:CD006936

Stead LF, Perera R, Lancaster T (2006) Telephone counselling for smoking cessation. Cochrane Database Syst Rev 3

Pötschke-Langer M, Schütz J, Kohn R (2008) Das Rauchertelefon des Deutschen Krebsforschungszentrums. Psychotherapie im Dialog 9:378–381

Kulzer B, Albus C, Herpertz S (2010) Praxisleitlinie der DGK: Psychosoziales und Diabetes mellitus. Diabetologie 5:S139–S145

Mezuk B, Eaton WW, Albrecht S (2008) Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 3:2383–2390

Chida Y, Hamer M (2008) An association of adverse psychosocial factors with diabetes mellitus: a meta-analytic review of longitudinal cohort studies. Diabetologia 51:2168–2178

Barnard KD, Skinner TC, Peveler R (2006) The prevalence of co-morbid depression in adults with type 1 diabetes: systematic literature review. Diabet Med 23:445–448

Feltz-Cornelis CM van der, Nuyen J, Stoop C (2010) Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: a systematic review and meta-analysis. Gen Hosp Psychiatry 32:380–395

Katon WJ, Lin EHB, Korff M von (2010) Collaborative care for patients with depression and chronic illnesses. N Engl J Med 363:2611–2620

Anderson RJ, Grigsby AB, Freedland KE (2002) Anxiety and poor glycemic control: a meta-analytic review of the literature. Int J Psychiatry Med 32:235–247

Goebel-Fabbri AE, Fikkan J, Franko DL (2008) Insulin restriction and associated morbidity and mortality in women with type 1 diabetes. Diabetes Care 31:415–419

AWMF (2010) Diagnostik und Therapie der Essstörungen

Zhao G, Ford ES, Li C (2009) Serious psychological distress and its associations with body mass index: findings from the 2007 Behavioral Risk Factor Surveillance System. Int J Public Health 54:20–36

Ladwig KH, Marten-Mittag B, Löwel H (2006) Synergistic effects of depressed mood and obesity on long-term cardiovascular risks in 1510 obese men and women: results from the MONICA-KORA Augsburg Cohort Study 1984–1998. Int J Obes (Lond) 30:1408–1414

Logue J, Murray H, Welsh P (2011) Obesity is associated with fatal coronary heart disease independently of traditional risk factors and deprivation. Heart 97:564–568

Jolliffe JA, Rees K, Taylor RS (2001) Exercise-based rehabilitation for coronary heart disease. Cochrane Database Syst Rev CD001800

Piepoli MF, Corrà U, Benzer W (2010) Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil 17:1–17

Mead GE, Morley W, Campbell P (2009) Exercise for depression. Cochrane Database Syst Rev CD004366

Babyak M, Blumenthal JA, Herman S (2000) Exercise treatment for major depression: maintenance of therapeutic benefit at 10 months. Psychosom Med 62:633–638

Blumenthal JA, Babyak MA, Carney RM (2004) Exercise, depression, and mortality after myocardial infarction in the ENRICHD trial. Med Sci Sports Exerc 36:746–755

Herring MP, Puetz TW, O‘Connor PJ (2012) Effect of exercise training on depressive symptoms among patients with a chronic illness: a systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 172:101–111

Schlicht W, Kanning M, Bös K (2003) Psychosoziale Interventionen zur Beeinflussung des Risikofaktors Bewegungsmangel. Statuskonferenz Psychokardiologie, Bd 10. VAS, Frankfurt

European Association of Cardiovascular Prevention and Rehabilitation Committee for Science Guidelines, EACPR, Corrà U (2010) Secondary prevention through cardiac rehabilitation: physical activity counselling and exercise training: key components of the position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. Eur Heart J 31:1967–1974

Rozanski A, Blumenthal JA, Davidson KW (2005) The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J Am Coll Cardiol 45:637–651

Dimsdale JE (2008) Psychological stress and cardiovascular disease. J Am Coll Cardiol 5:1237–1246

Hamer M, Molloy GJ, Stamatakis E (2008) Psychological distress as a risk factor for cardiovascular events: pathophysiological and behavioral mechanisms. J Am Coll Cardiol 52:2156–2162

Stringhini S, Sabia S, Shipley M (2010) Association of socioeconomic position with health behaviors and mortality. JAMA 303:1159–1166

Woodward M, Brindle P, Tunstall-Pedoe H (2007) Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart 93:172–176

Siegrist J, Dragano N (2008) Psychosocial stress and disease risks in occupational life. Results of international studies on the demand-control and the effort-reward imbalance models. Bundesgesundheitsbl Gesundheitsforsch Gesundheitssch 51:305–312

Eller NH, Netterstrom B, Gyntelberg F (2009) Work-related psychosocial factors and the developement of ischemic heart disease. A systematic review. Cardiol Rev 17:83–97

Virtanen M, Ferrie JE, Singh-Manoux A (2010) Overtime work and incident coronary heart disease: the Whitehall II prospective cohort study. Eur Heart J 31:1737–1744

Denollet J, Schiffer A, Spek V (2010) A general propensity to psychological distress affects cardiovascular outcomes. Evidence from research on the type D (distressed) personality profile. Circ Cardiovasc Qual Outcomes 3:546–557

Grande G, Romppel M, Barth J (2012) Association between type d personality and prognosis in patients with cardiovascular diseases: a systematic review and meta-analysis. Ann Behav Med 43:299–310

Pelle AJ, Pedersen SS, Schiffer AA (2010) Psychological distress and mortality in systolic heart failure. Circ Heart Fail 3:261–267

Grande G, Romppel M, Vesper JM (2011) Type D Personality and all-cause mortality in cardiac patients – data from a German Cohort Study. Psychosom Med 73:548–556

Coyne JC, Jaarsma T, Luttik ML (2011) Lack of prognostic value of type d personality for mortality in a large sample of heart failure patients. Psychosom Med 73:557–562

Nicholson A, Kuper H, Hemingway H (2006) Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146538 participants in 54 observational studies. Eur Heart J 27:2763–2774

Williams JE, Mosley TH Jr, Kop WJ (2010) Vital exhaustion as a risk factor for adverse cardiac events (from the Atherosclerosis Risk in Communities [ARIC] study). Am J Cardiol 105:1661–1665

Thombs BD, Bass EB, Ford DE (2006) Prevalence of depression in survivors of acute myocardial infarction. Review of the evidence. J Gen Intern Med 21:30–38

Newcomer JW, Hennekens CH (2007) Severe mental illness and risk of cardiovascular disease. JAMA 298:1794–1796

Roest AM, Martens EJ, Jonge P de (2010) Anxiety and risk of incident coronary heart disease: a meta-analysis. J Am Coll Cardiol 56:38–46

Roest AM, Martens EJ, Denollet J (2010) Prognostic association of anxiety following myocardial infarction with mortality and new cardiac events: a meta-analysis. Psychosom Med 72:563–569

Meyer T, Buss U, Herrmann-Lingen C (2010) Role of cardiac disease severity and predictive value of anxiety for all-cause mortality. Psychosom Med 72:9–15

Chida Y, Steptoe A (2009) The association of anger and hostility with future coronary heart disease: a meta-analytic review of prospective evidence. J Am Coll Cardiol 53:936–946

Myrtek M (2001) Meta-analyses of prospective studies on coronary heart disease, type A personality, and hostility. Int J Cardiol 79:245–251

Spindler H, Pedersen SS (2005) Posttraumatic stress disorder in the wake of heart disease: prevalence, risk factors, and future research directions. Psychosom Med 67:715–723

Nawrot TS, Perez L, Künzli N (2011) Public health importance of triggers of myocardial infarction: a comparative risk assessment. Lancet 373:732–740

Leor J, Kloner RA (1996) The Northridge earthquake as a trigger for acute myocardial infarction. Am J Cardiol 77:1230–1232

Wilbert-Lampen U, Leistner D, Greven S (2008) Cardiovascular events during world cup soccer. N Engl J Med 358:475–483

Ladwig KH, Gärtner C, Walz L (2009) The inner barrier: how health psychology concepts contribute to the explanation of prehospital delays in acute myocardial infarction: a systematic analysis of the current state of knowledge. Psychother Psychosom Med Psychol 59:5

Graham I, Atar D, Borch-Johanson K (2007) European guidelines on cardiovascular disease prevention in clinical practice: full text. Eur J Cardiovasc Prev Rehab 14(Suppl. 2):1–113

Whalley B, Rees K, Davies P (2011) Psychological interventions for coronary heart disease. Cochrane Database of Systematic reviews CD002902

Berkman LF, Blumenthal J, Burg M (2003) Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 289:3106–3116

Barth J, Paul J, Härter M (2005) Inpatient psychotherapeutic treatment for cardiac patients with depression in Germany: short term results. GMS Psychosoc Med 2:Doc04

Freedland KE, Skala JA, Carney RM (2009) Treatment of depression after coronary bypass surgery. A randomized controlled trial. Arch Gen Psychiatry 66:387–396

Davidson KW, Rieckmann N, Clemow L (2010) Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial. Arch Intern Med 7:600–608

Lesperance F, Frasure-Smith N, Koszycki D (2007) Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 297:367–379

Rollman BL, Belnap BH, Lenager MS (2009) Telephone-delivered collaborative care for treating post-CABG depression. A randomized controlled trial. JAMA 302:2095–2103

Baumeister H, Hutter N, Bengel J (2011) Psychological and pharmacological interventions for depression in patients with coronary artery disease. Cochrane Database Syst Rev 9:CD008012

Carney RM, Blumenthal JA, Freedland KE (2004) Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) study. Psychosom Med 66:466–474

Jonge P de, Honig A, Melle JP van (2007) Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events. Am J Psychiatry 164:1371–1378

DGPPN, BÄK, KBV (2009) S3-Leitlinie/Nationale Versorgungsleitlinie Unipolare Depression – Langfassung

Albus C, Beutel ME, Deter HC (2011) A stepwise psychotherapy intervention for reducing risk in coronary artery disease (SPIRR-CAD) – rationale and design of a multicenter, randomized trial. J Psychosom Res 71:215–222

Glassmann AH, O’Connor CM, Califf RM (2002) Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 288:701–709

Strik JJ, Honig A, Lousberg R (2000) Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial. Psychosom Med 62:783–789

Glassmann AH, Bigger JT, Gaffney M (2006) Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefit. Arch Gen Psyciatry 63:283–288

Honig A, Kuyper AMG, Schene AH (2007) Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine. Psychosom Med 69:606–613

Narayan SM, Stein MB (2009) Do depression or antidepressants increase cardiovascular mortality? The absence of proof might be more important than the proof of absence. J Am Coll Cardiol 53:959–961, 958

Whang W, Kubzansky LD, Kawachi I (2009) Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses‘ Health Study. J Am Coll Cardiol 53:950–958

Taylor CB, Youngblood ME, Catellier D (2005) Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry 62:792–798

Abajo FJ de, Garcia-Rodriguez LA (2008) Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents. Arch Gen Psychiatry 62:795–803

Kim DH, Daskalakis C, Whellan DJ (2009) Safety of selective serotonin reuptake inhibitor in adults undergoing coronary artery bypass grafting. Am J Cardiol 103:1391–1395

Roose SP, Laghrissi-Thode F, Kennedy JS (1998) Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 279:287–291

Johnson EM, Whyte E, Mulsant BH (2006) Cardiovascular changes associated with venlafaxine in the treatment of late-life depression. Am J Geriatr Psychiatry 14:796–802

Melle JP van, Jonge P de, Honig A (2007) Effects of antidepressant treatment following myocardial infarction. Br J Psychiatry 190:460–466

Glassmann AH, Bigger JT Jr, Gaffney M (2009) Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participants. Arch Gen Psychiatry 66:1022–1029

Connerney I, Shapiro PA, McLaughlin JS (2001) Relation between depression after coronary artery bypass surgery and 12-month outcome: a prospective study. Lancet 358:1766–1771

Blumenthal JA, Lett HS, Babyak MA (2003) Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet 362:604–609

McKenzie LH, Simpson J, Stewart M (2010) A systematic review of pre-operative predictors of post-operative depression and anxiety in individuals who have undergone coronary artery bypass graft surgery. Psychol Health Med 15:74–93

Selnes OA, McKhann GM, Borowicz LM Jr (2006) Cognitive and neurobehavioral dysfunction after cardiac bypass procedures. Neurol Clin 24:133–145

Rimington H, Weinman J, Chambers JB (2010) Predicting outcome after valve replacement. Heart 96:118–123

Aicher D, Holz A, Feldner S (2011) Quality of life after aortic valve surgery: replacement versus reconstruction. J Thorac Cardiovasc Surg 142:e19–e24

Zipfel S, Schneider A, Wild B (2002) Effect of depressive symptoms on survival after heart transplantation. Psychosom Med 64:740–747

Havik OE, Sivertsen B, Relbo A (2007) Depressive symptoms and all-cause mortality after heart transplantation. Transplantation 84:97–103

Dew MA, Kormos RL, Roth LH (1999) Early post-transplant medical compliance and mental health predict physical morbidity and mortality one to three years after heart transplantation. J Heart Lung Transplant 18:549–562

Köllner V, Einsle F, Schade I (2003) Psychosoziale Belastung und Lebensqualität bei Patienten nach Herz- oder Lungentransplantation. Z Psychosom Med Psychother 49:262–274

Young E, Eddleston J, Ingleby S (2005) Returning home after intensive care: a comparison of symptoms of anxiety and depression in ICU and elective cardiac surgery patients and their relatives. Intensive Care Med 31:86–91

Dew MA, Myaskovsky L, DiMartini AF (2004) Onset, timing and risk for depression and anxiety in family caregivers to heart transplant recipients. Psychol Med 34:1065–1082

Bunzel B, Laederach-Hofmann K, Wieselthaler G (2007) Mechanical circulatory support as a bridge to heart transplantation: What remains? Long-term emotional sequelae in patients and spouses. J Heart Lung Transplant 26:384–389

Medi C, Kalman JM, Freedman SB (2009) Supraventricular tachycardia. Med J Aust 190:255–260

McCabe PJ (2010) Psychological distress in patients diagnosed with atrial fibrillation: the state of the science. J Cardiovasc Nurs 25:40–51

Thrall G, Lane D, Carroll D (2006) Quality of life in patients with atrial fibrillation: a systematic review. Am J Med 119:448 e441–419

Ladwig KH, Ischinger NF, Ronel J (2011) Treating ICD patients at the end of their lives: attitudes, knowledge, and behavior of doctors and patients. A critical literature analysis. Herzschrittmacherther Elektrophysiol 22:151–156

Braunschweig F, Boriani G, Bauer A (2010) Management of patients receiving implantable cardiac defibrillator shocks: recommendations for acute and long-term patient management. Europace 12:1673–1690

Magyar-Russell G, Thombs BD, Cai JX (2011) The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: a systematic review. J Psychosom Res 71:223–231

Cho E, Känel R von, Marten-Mittag B (2012) Determinants and trajectory of phobic anxiety in patients living with an implantable cardioverter defibrillator. Heart 98:6

Whang W, Albert C, Sears SF (2005) Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study. J Am Coll Cardiol 45:1090–1095

Tzeis S, Kolb C, Baumert J (2011) Effect of depression on mortality in implantable cardioverter defibrillator recipients-findings from the prospective LICAD study. Pacing Clin Electrophysiol 34:991–997

Ladwig KH, Baumert J, Marten-Mittag B (2008) Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study. Arch Gen Psychiatry 65:1324–1330

Pedersen SS, Broek K van den, Sears SF Jr (2007) Psychologica intervention following implantation of an implantable defibrillator: a review and future recommendations. Pacing Clin Electrophysiol 30:1546–1554

Salmoirago-Blotcher E, Ockene IS (2009) Methodological limitations of psychosocial interventions in patients with an implantable cardioverter-defibrillator (ICD) A systematic review. BMC Cardiovasc Disord 9:56

Irvine J, Firestone J, Ong L (2011) A randomized controlled trial of cognitive behavior therapy tailored to psychological adaption to an implantable cardioverter defibrillator. Psychosom Med 73:226–233

Crössmann A, Schulz S, Kühlkamp V (2010) A randomized controlled trial of secondary prevention of anxiety and distress in a German sample of patients with an implantable cardioverter defibrillator. Psychosom Med 72:434–441

Jordan J, Titscher G, Kirsch H (2011) Treatment manual for psychotherapy of acute and posttraumatic stress disorders after multiple ICD shocks. Herzschrittmacherther Elektrophysiol 22:189–201

Wenzel-Seifert K, Wittmann M, Haen E (2011) QTc prolongation by psychotropic drugs and the risk of torsade de pointes. Dtsch Arztebl Int 108:687–693

Honkola J, Hookana E, Malinen S (2012) Psychotropic medications and the risk of sudden cardiac death during an acute coronary event. Eur Heart J 33:745–751

Rutledge T, Reis VA, Linke SE (2006) Depression in heart failure. A meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. JACC 48:1527–1537

Hobbs FD, Kenkre JE, Roalfe AK (2002) Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. Eur J Heart Fail 23:1867–1876

Juenger J, Schellberg D, Kraemer S (2002) Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart 87:235–241

Faller H, Storck S, Schuler M (2009) Depression and disease severity as predictors of health-related quality of life in patients with chronic heart failure: a structural equation modeling approach. J Card Fail 15:286–292

Dickstein KA, Cohen-Solal A, Filippatos G (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29:2388–2442

Wal MH van der, Jaarsma T (2005) Non-compliance in patients with heart failure; how can we manage it? Eur J Heart Fail 7:5–17

Laufs U, Rettig-Ewen V, Böhm M (2011) Strategies to improve drug adherence. Eur Heart J 32:264–268

Cutler DM, Everett W (2010) Thinking outside the pillbox – medication adherence as a priority for health care reform. New Engl J Med 362:1553–1555

McAlister F, Lawson F, Teo K (2001) A systematic review of randomized trials of disease management programs in heart failure. Am J Med 110:378–384

Koehler F, Winkler S, Schieber M (2012) Telemedicine in heart failure: pre-specified and exploratory subgroup analyses from the TIM-HF trial. Int J Cardiol 161(3):143–150

Angermann CE, Störk S, Gerlbrich G (2012) Mode of action and effects of standardized collaborative disease managerment on mortality and morbidity in patients with systolic heart failure: the Interdisciplinary Network for Heart Failure (INH) Study. Circ Heart Fail 5:25–35

Piepoli MF, Conraads V, Corra U (2011) Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation. Eur J Heart Fail 13:347–357

Conraads V, Deaton C, Piotrowicz E (2012) Adherence of heart failure patients to exercis: barriers and possible solutions: a position statement of the Study Group on Exercise Training in Heart Failure of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 14:451–458

Bundesärztekammer, Kassenärztliche Bundesvereinigung, Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (2012) Nationale VersorgungsLeitlinie Chronische Herzinsuffizienz, Langfassung. Version 1.5

O’Connor CM, Jiang W, Kuchibhatla M (2010) Safety and efficacy of sertraline for depression in patients with heart failure. JACC 56:692–699

Albus C, Herrmann-Lingen C (2007) Funktionelle Störungen in der Kardiologie. Psychosomatik und Konsiliarpsychiatrie 1:120–124

Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin (DEGAM) (2011) Brustschmerz -DEGAM-Leitlinie Nr. 15

Mayou RA, Bryant BM, Sanders D (1997) A controlled trial of cognitive behavioural therapy for non-cardiac chest pain. Psychosom Med 27:1021–1031

Mayou R, Sprigings D, Birkhead J (2002) A randomized controlled trial of a brief educational and psychological intervention for patients presenting to a cardiac clinic with palpitation. Psychol Med 32:699–706

Potts SG, Lewin R, Fox KA (1999) Group psychological treatment for chest pain with normal coronary arteries. QJM 92:81–86

Cannon RO, Quyyumi AA, Mincemoyer R (1994) Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med 330:1411–1417

Sanders D, Bass C, Mayou RA (1997) Non-cardiac chest pain: why was a brief intervention apparently ineffective? Psychol Med 27:1033–1040

Löwe B, Spitzer RL, Zipfel S (2001) PHQ-D Gesundheitsfragebogen für Patienten

Herrmann-Lingen C, Buss U, Snaith RP (2011) HADS-D – Hopital Anxiety and Depression Scale – Deutsche Version. 3. aktualisierte und neu normierte Aufl. Huber, Bern

Bundespsychotherapeutenkammer (Hrsg) (2011) BPtK-Studie zu Wartezeiten in der ambulanten psychotherapeutischen Versorgung. Umfrage der Landespsychotherapeutenkammern und der BPtK

DRV Bund (Hrsg) (2009) Strukturqualität von Reha-Einrichtungen – Anforderungen der Deutschen Rentenversicherung – Stationäre medizinische Reha-Einrichtungen